Pharma and Biotech
Competitors: | Hemogenyx Pharmaceuticals |
Executive Director: | Daniel Gooding |
Independent Non-Executive Director: | Madeleine Kennedy |
Non-Executive Chairman: | Julian Gilbert |
Non-Executive Dir: |
Address: | C/O Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ |
Phone: | +44 (0)1223 627222 |
Website: | https://nuformix.com/ |
Sector: | Pharma and Biotech(LSE) |
ISIN: | GB00BYW79Y38 |
Currency | UK Pounds |
Share Price | 0.11p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 0.16 |
52 Week Low | 0.048 |
Volume | 8,311,034 |
Shares Issued | 1,995.71m |
Market Cap | £2.20m |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:25 | 277,749 @ 0.11p |
15:09 | 1,103,377 @ 0.10p |
14:38 | 973,524 @ 0.10p |
13:58 | 1,001,256 @ 0.11p |
12:55 | 861,240 @ 0.12p |
You are here: research